Cargando…

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer

PURPOSE: Previous studies have noted increased utilization of perioperative chemotherapy over time. The goal of this study was to determine trends in perioperative chemotherapy use within a contemporary population. MATERIALS AND METHODS: The National Cancer Database was queried for patients diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales:	McFerrin, Coleman, Davaro, Facundo, May, Allison, Raza, Syed, Siddiqui, Sameer, Hamilton, Zachary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606117/ https://www.ncbi.nlm.nih.gov/pubmed/32985142 http://dx.doi.org/10.4111/icu.20200132

Ejemplares similares

Contemporary analysis of epididymal tumors using a national database
por: Bhatt, Rohit, et al.
Publicado: (2021)

Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy
por: Sui, Wilson, et al.
Publicado: (2017)

Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension
por: Murthy, Prithvi B., et al.
Publicado: (2023)

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
por: Eldefrawy, Ahmed, et al.
Publicado: (2012)

Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer
por: Sawasdee, Anupong, et al.
Publicado: (2022)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Dont Worry be Happy/
por: Bobby Mc.Ferrin

A Case of Heterotopic Ossification in Papillary Renal Cell Carcinoma Type 2
por: Davaro, Facundo, et al.
Publicado: (2020)

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
por: Matsubara, Nobuaki, et al.
Publicado: (2013)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A Systematic Review and Meta-Analysis
por: Zhu, Ziwei, et al.
Publicado: (2022)

Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991)

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
por: Del Bene, Gabriella, et al.
Publicado: (2018)

Minimally invasive management versus open surgery in the treatment of penetrating bladder injuries: a retrospective cohort study
por: Culhane, John, et al.
Publicado: (2021)

Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis
por: Cai, Zhiyong, et al.
Publicado: (2021)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: An analysis of the National Cancer Database
por: Grant, Campbell M, et al.
Publicado: (2019)

Evolution of the Max and Mlx Networks in Animals
por: McFerrin, Lisa G., et al.
Publicado: (2011)

The non-random clustering of non-synonymous substitutions and its relationship to evolutionary rate
por: McFerrin, Lisa G, et al.
Publicado: (2011)

A Novel N-Terminal Domain May Dictate the Glucose Response of Mondo Proteins
por: McFerrin, Lisa G., et al.
Publicado: (2012)

How the water-soluble hemicarcerand incarcerates guests at room temperature decoded with modular simulations
por: McFerrin, Katherine G., et al.
Publicado: (2021)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Abstract 11. The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Nipple-Sparing Mastectomy
por: Frey, Jordan D., et al.
Publicado: (2017)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Changes in neoadjuvant chemotherapy utilization in muscle invasive bladder cancer treatment: a tertiary center retrospective study
por: Gronostaj, Katarzyna, et al.
Publicado: (2020)

Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
por: Jayaratna, Isuru S., et al.
Publicado: (2015)

Neoadjuvant Chemotherapy in Neuroendocrine Bladder Cancer: A Case Report
por: Prelaj, Arsela, et al.
Publicado: (2016)

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
por: Sherif, Amir, et al.
Publicado: (2018)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
por: Carvalho, Filipe LF., et al.
Publicado: (2020)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
por: Elsayed, Dalia Hamouda, et al.
Publicado: (2023)

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
por: Au, Daniel, et al.
Publicado: (2021)

Surgical resection of orbital primitive neuroectodermal tumor without adjuvant chemotherapy
por: Mehmood, Faizan, et al.
Publicado: (2022)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
por: Hirahara, Noriyuki, et al.
Publicado: (2022)

An Epigenomic Approach to Improving Response to Neoadjuvant Cisplatin Chemotherapy in Bladder Cancer
por: Xylinas, Evanguelos, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_56qg4oqcl8sf16u45esf5qapsv